FDA Drug Safety Communication: FDA warns of serious immune system reaction with seizure and mental health medicine lamotrigine (Lamictal)
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body ’s infection-fighting immune system.
This study offers preliminary evidence that immune responsivity to stress induction could serve as a mechanism of treatment for mood disorders in youth, indicating a potential marker for more personalized model of healthcare.
CONCLUSIONS: For most mental disorders, refugees were less likely to be admitted to hospital for suicide attempt or die by suicide compared with Swedish-born individuals. Further research on risk and protective factors for suicide attempt and suicide among refugees with mental disorders is warranted. DECLARATION OF INTEREST: None. PMID: 31608856 [PubMed - as supplied by publisher]
J. Mater. Chem. A, 2019, Accepted Manuscript DOI: 10.1039/C9TA09641H, PaperAmin Rabiei Baboukani, Iman Khakpour, Vadym Drozd, Anis Allagui, Chunlei Wang Black phosphorus (BP) is a two-dimensional material that has gained attention for various applications due to its exceptional physical and chemical properties such as tunable bandgap and high charge carrier... The content of this RSS Feed (c) The Royal Society of Chemistry
ConclusionThe utilization of a stone retrieval basket is a novel and effective method for retrieving a wide based endometrial polyp following incomplete resection with hysteroscopic scissors.
ConclusionThe pinpoint accuracy of the bipolar method allowed for safe and complete dissection.
ConclusionThese modifications to the technique will help shorten operation times and reduce complications of LSC.
Literature review shows increased likelihood of idiopathic PD with previous diagnosis of BD
Conditions: Bipolar Disorder; Substance Use Disorders Interventions: Behavioral: Integrated Treatment Adherence Program for Veterans (ITAP-VA); Behavioral: Safety Assessment and Follow-up Evaluation (SAFE) Sponsor: Providence VA Medical Center Not yet recruiting
Conditions: Bipolar I Disorder; Schizophrenia Intervention: Drug: Iloperidone Sponsor: Vanda Pharmaceuticals Recruiting
Publication date: February 2020Source: Materials Science in Semiconductor Processing, Volume 106Author(s): V.L. Patil, Aditya A. Patil, S.V. Patil, N.A. Khairnar, N.L. Tarwal, S.A. Vanalakar, R.N. Bulakhe, Insik In, P.S. Patil, T.D. DongaleAbstractThe memristive devices are getting a lot of interest in recent years due to its applications in the field of resistive memory and brain-inspired computing. In the present work, we have developed a ZnO memristive device using the reflux method. We have demonstrated non-volatile memory properties and mimicked the basic synaptic properties of using Al/ZnO/FTO thin film device. The s...